300871 回盛生物
按盤價 
9.400 +0.200 (+2.174%)
9.400 +0.200 (+2.174%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.087 | 1.100 | 3.336 | 8.864 | 17.088 |
| 總資產報酬率 ROA (%) | -0.550 | 0.563 | 1.839 | 5.913 | 12.501 |
| 投入資產回報率 ROIC (%) | -0.633 | 0.660 | 2.090 | 6.510 | 14.287 | 邊際利潤分析 |
| 銷售毛利率 (%) | 22.666 | 20.916 | 22.032 | 27.175 | 37.027 |
| 營業利潤率 (%) | -10.390 | 1.479 | 5.783 | 15.160 | 22.704 |
| 息稅前利潤/營業總收入 (%) | -5.688 | 3.615 | 6.922 | 14.701 | 22.144 |
| 淨利潤/營業總收入 (%) | -7.933 | 1.646 | 5.153 | 13.337 | 19.314 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 58.040 | 27.630 | 105.469 | 88.995 | 97.729 |
| 價值變動淨收益/利潤總額(%) | 68.446 | 203.952 | 12.361 | 2.920 | 0.482 |
| 營業外收支淨額/利潤總額(%) | 0.273 | -21.231 | -4.316 | -0.130 | -0.275 | 償債能力分析 |
| 流動比率 (X) | 1.602 | 1.621 | 1.679 | 3.177 | 3.476 |
| 速動比率 (X) | 1.253 | 1.328 | 1.432 | 2.717 | 3.100 |
| 資產負債率 (%) | 49.570 | 49.276 | 48.432 | 40.954 | 0.213 |
| 帶息債務/全部投入資本 (%) | 39.918 | 37.232 | 36.723 | 33.241 | 11.071 |
| 股東權益/帶息債務 (%) | 143.151 | 159.755 | 164.582 | 195.408 | 783.689 |
| 股東權益/負債合計 (%) | 101.733 | 102.940 | 106.476 | 144.179 | 369.670 |
| 利息保障倍數 (X) | -1.203 | 1.509 | 5.022 | -33.417 | -44.427 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 139.094 | 115.881 | 100.276 | 78.329 | 69.415 |
| 存貨周轉天數 (天) | 142.827 | 95.456 | 97.174 | 89.025 | 73.415 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 05/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
